Show simple item record

dc.contributor.authorGLASSMAN, Amanda
dc.contributor.authorTUBEUF, Sandy
dc.contributor.authorVAN DE RIJT, Arnout
dc.contributor.editorIMMERGUT, Ellen M.
dc.date.accessioned2021-05-28T14:52:48Z
dc.date.available2021-05-28T14:52:48Z
dc.date.issued2021
dc.identifier.urihttps://hdl.handle.net/1814/71461
dc.descriptionThis contribution was delivered online on 6 May 2021 on the occasion of the hybrid 2021 edition of EUI State of the Union on ‘Europe in a Changing World'.
dc.description.abstractThis panel will address two key problems underpinning the ethics and efficacy of the distribution of the COVID-19 vaccine. First, the key assumptions that guide the ethics of vaccine distribution remain uncertain, such as whether the vaccines stop transmission or only prevent severe illness. Second, the most efficacious methods for distribution may conflict with both ethical guidelines and public sentiment. Ethical discussions have revolved around protecting the vulnerable, while public opinion often is based on ideas about ‘deservingness.’ But neither perspective may actually be the best guide for actually stopping the pandemic. This panel will discuss scientific findings based on simulation models of vaccine distribution, public opinion surveys, and comparative policy analysis of vaccine distribution.en
dc.language.isoen
dc.publisherEuropean University Institute
dc.relation.ispartofseriesThe State of the Union Conferenceen
dc.relation.ispartofseries2021en
dc.relation.ispartofseriesPublic Healthen
dc.relation.urihttps://www.youtube.com/watch?v=tdUAK1GMIvU&t=14683s
dc.relation.urihttps://stateoftheunion.eui.eu/public-health/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCOVID-19
dc.subjectCovid-19
dc.subjectCoronavirus
dc.titleEthics and efficiency in vaccine distributionen
dc.typeVideoen
eui.subscribe.skiptrue


Files associated with this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record